KeyCorp reaffirmed their hold rating on shares of DaVita HealthCare Partners Inc. (NYSE:DVA) in a report issued on Tuesday. KeyCorp also issued estimates for DaVita HealthCare Partners’ FY2018 earnings at $3.58 EPS and FY2019 earnings at $3.94 EPS.

DVA has been the subject of several other reports. BidaskClub lowered DaVita HealthCare Partners from a sell rating to a strong sell rating in a research report on Saturday, August 5th. Jefferies Group LLC lowered DaVita HealthCare Partners from a buy rating to a hold rating and boosted their price objective for the company from $64.89 to $70.00 in a research report on Monday, June 26th. Zacks Investment Research downgraded DaVita HealthCare Partners from a hold rating to a sell rating in a research report on Tuesday, July 4th. J P Morgan Chase & Co downgraded DaVita HealthCare Partners from a neutral rating to an underweight rating in a research report on Monday. Finally, Royal Bank Of Canada reaffirmed a hold rating and set a $64.00 price target on shares of DaVita HealthCare Partners in a research report on Wednesday, September 6th. Four equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company’s stock. DaVita HealthCare Partners currently has a consensus rating of Hold and an average price target of $66.50.

Shares of DaVita HealthCare Partners (NYSE DVA) opened at 54.40 on Tuesday. DaVita HealthCare Partners has a 12-month low of $53.58 and a 12-month high of $70.16. The firm has a market capitalization of $10.40 billion, a PE ratio of 8.29 and a beta of 0.90. The company’s 50 day moving average is $58.34 and its 200 day moving average is $63.00.

DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The business had revenue of $3.88 billion during the quarter, compared to analyst estimates of $3.82 billion. During the same period in the previous year, the firm earned $1.01 EPS. DaVita HealthCare Partners’s quarterly revenue was up 4.3% compared to the same quarter last year. On average, analysts forecast that DaVita HealthCare Partners will post $3.59 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “DaVita HealthCare Partners’ (DVA) “Hold” Rating Reiterated at KeyCorp” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/13/davita-healthcare-partners-dva-hold-rating-reiterated-at-keycorp.html.

DaVita HealthCare Partners declared that its board has authorized a share repurchase program on Tuesday, October 10th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

A number of large investors have recently added to or reduced their stakes in the business. Eqis Capital Management Inc. boosted its position in DaVita HealthCare Partners by 62.5% during the 3rd quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock worth $444,000 after acquiring an additional 2,873 shares during the last quarter. Oak Associates Ltd. OH boosted its position in DaVita HealthCare Partners by 21.1% during the 2nd quarter. Oak Associates Ltd. OH now owns 185,195 shares of the company’s stock worth $11,993,000 after acquiring an additional 32,285 shares during the last quarter. Flinton Capital Management LLC boosted its position in DaVita HealthCare Partners by 10.7% during the 2nd quarter. Flinton Capital Management LLC now owns 152,830 shares of the company’s stock worth $9,898,000 after acquiring an additional 14,756 shares during the last quarter. Cibc World Markets Corp boosted its position in DaVita HealthCare Partners by 35.3% during the 2nd quarter. Cibc World Markets Corp now owns 22,006 shares of the company’s stock worth $1,425,000 after acquiring an additional 5,746 shares during the last quarter. Finally, Accident Compensation Corp boosted its position in DaVita HealthCare Partners by 147.5% during the 2nd quarter. Accident Compensation Corp now owns 15,100 shares of the company’s stock worth $978,000 after acquiring an additional 9,000 shares during the last quarter. 83.27% of the stock is owned by hedge funds and other institutional investors.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.